These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17349437)

  • 1. Hepatocellular cancer: a guide for the internist.
    Parikh S; Hyman D
    Am J Med; 2007 Mar; 120(3):194-202. PubMed ID: 17349437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatocellular carcinoma.
    Bosch FX; Ribes J; Cléries R; Díaz M
    Clin Liver Dis; 2005 May; 9(2):191-211, v. PubMed ID: 15831268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
    Wang Q; Luan W; Villanueva GA; Rahbari NN; Yee HT; Manizate F; Hiotis SP
    J Dig Dis; 2012 Apr; 13(4):214-8. PubMed ID: 22435506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M
    Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma.
    Yoneyama K; Miyagishi K; Kiuchi Y; Shibata M; Mitamura K
    J Gastroenterol; 2002; 37(12):1028-34. PubMed ID: 12522534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
    Leykum LK; El-Serag HB; Cornell J; Papadopoulos KP
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):508-12. PubMed ID: 17382601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can hepatocellular cancer screening increase the proportion of long-term survivors?
    Gannon CJ; Izzo F; Aloia TA; Pignata S; Nasti G; Vallone P; Orlando R; Scordino F; Curley SA
    Hepatogastroenterology; 2009; 56(93):1152-6. PubMed ID: 19760960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
    Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma.
    Marrero JA
    Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: overcoming challenges in disease management.
    Gish RG
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):252-61. PubMed ID: 16527686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of hepatitis C viral infection.
    Muir AJ
    Semin Gastrointest Dis; 2000 Apr; 11(2):54-61. PubMed ID: 10803630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Cancer Working Group report.
    Kudo M; Han KH; Kokudo N; Cheng AL; Choi BI; Furuse J; Izumi N; Park JW; Poon RT; Sakamoto M
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i19-27. PubMed ID: 20870915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.